Tumor organoids can help overcome therapy resistance of colorectal cancer
- Nov 4, 2021
- 3 min
Structure of a promiscuous protein will help scientists design better drugs
- Nov 4, 2021
- 2 min
Affimed Announces New Innate Cell Engager AFM28 Targeting CD123 to Treat Acute Myeloid Leukemia
- Nov 4, 2021
- 3 min
Strengthening the Heidelberg-Mainz Axis towards faster biomedical innovation
- Nov 3, 2021
- 2 min
BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck
- Oct 27, 2021
- 2 min
Evotec SE: Translational BRIDGE beLAB2122 in collaboration with BMS identifies first project
- Oct 27, 2021
- 1 min
New Member: Welcome in our cluster to designfunktion
- Oct 27, 2021
- 3 min
How the "thermostat" in the brain measures impending overheating
- Oct 25, 2021
- 2 min
Characterising protein phosphosite function at scale
- Oct 25, 2021
- 2 min
Recognizing rare radiation-related secondary tumors in children
- Oct 25, 2021
- 4 min
Tackling the collateral damage from antibiotics
- Oct 22, 2021
- 3 min
EMBL reinforces collaboration with Belgian scientific community
- Oct 22, 2021
- 2 min
RHEACELL is developing a novel cell-therapy agent for the treatment of chronic venous ulcers
- Oct 22, 2021
- 1 min
EMBL DG joins National Academy of Medicine
- Oct 22, 2021
- 1 min
Germany approves novel cell therapy extracted from skin